Literature DB >> 105056

Risk factors for nosocomial infection.

J Freeman, J E McGowan.   

Abstract

Studies of nosocomial infection are difficult to evaluate because of differences in the relative susceptibility of patients to the acquisition of such infections, the use of different methods of surveillance, and the frequent failure to distinguish between measurements of incidence and of prevalence. A standardized approach to these variables has been tested at a large municipal hospital. The systematic identification of potential risk factors for nosocomial infection allows the evaluation of the individual components of risk, valid epidemiologic comparisons between hospital populations, and a more accurate estimate of the potential cost-effectiveness of activities for the control of infection. The data indicate that it is feasible to calculate the relative risk of nosocomial infection for each patient, using basic criteria obtainable at the bedside, supplemented with other generally available information. The risk of infection must be calculated per day rather than per admission to separate the effect of long hospital stay from the effect of high daily risk. Certain underlying diseases, procedures, hospital services, and categories of age, sex, race, and urgency of admission were all found to be significant risk factors for nosocomial infection.

Entities:  

Mesh:

Year:  1978        PMID: 105056     DOI: 10.1093/infdis/138.6.811

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions.

Authors:  M Lipsitch; C T Bergstrom; B R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Acinetobacter baumannii: a threat for the ICU?

Authors:  Jordi Rello; Emili Diaz
Journal:  Intensive Care Med       Date:  2003-02-13       Impact factor: 17.440

3.  The microbiologic risk of invasive haemodynamic monitoring in open-heart patients requiring prolonged ICU treatment.

Authors:  J Damen
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

4.  Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study.

Authors:  R C Spencer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

5.  Surveillance of infections in hospital: agents and antibiotic-resistance.

Authors:  F Riccardi; A Noce; S Falco; P Giudiceandrea; L Palombi; A Panà
Journal:  Eur J Epidemiol       Date:  1997-02       Impact factor: 8.082

6.  Infection after intracerebral hemorrhage: risk factors and association with outcomes in the ethnic/racial variations of intracerebral hemorrhage study.

Authors:  Aaron S Lord; Carl D Langefeld; Padmini Sekar; Charles J Moomaw; Neeraj Badjatia; Anastasia Vashkevich; Jonathan Rosand; Jennifer Osborne; Daniel Woo; Mitchell S V Elkind
Journal:  Stroke       Date:  2014-10-14       Impact factor: 7.914

7.  Towards a global perspective of nosocomial infections.

Authors:  R P Wenzel
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

8.  Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization.

Authors:  A A Vegas; V M Jodra; M L García
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

9.  Hospital stay length as an effect modifier of other risk factors for nosocomial infection.

Authors:  M Delgado-Rodríguez; A Bueno-Cavanillas; R López-Gigosos; J de Dios Luna-Castillo; J Guillén-Solvas; O Moreno-Abril; B Rodríguez-Tuñas; A Cueto-Espinar; R Rodríguez-Contreras; R Gálvez-Vargas
Journal:  Eur J Epidemiol       Date:  1990-03       Impact factor: 8.082

10.  Preoperative stay as a risk factor for nosocomial infection.

Authors:  A Bueno Cavanillas; R Rodrìguez-Contreras; M Delgado Rodriguez; O Moreno Abril; R López Gigosos; J Guillen Solvas; R Gálvez Vargas
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.